LigaChem Biosciences, Inc.

Quick facts

Phase 2 pipeline

• Bedaquiline, Delamanid, Moxifloxacin · Infectious Disease
  Inhibits Mycobacterium tuberculosis ATP synthase
• LCB01-0371 1200mg, QD
• LCB01-0371 400mg, BID
• LCB01-0371 800mg, BID · Oncology
  LCB01-0371 is a selective inhibitor of lysine-specific demethylase 1 (LSD1) that restores gene expression silenced by aberrant histone methylation in cancer cells.
• LCB01-0371 800mg, QD
• Tubes 3~5Tablet, QD
• Zyvox 600mg, BID

Phase 1 pipeline

• LCB01-0371
• LCB02A
• LCB84

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• LigaChem Biosciences, Inc. portfolio CI brief
• LigaChem Biosciences, Inc. pipeline updates RSS